KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Non-cash Items: 2012-2019

Historic Non-cash Items for Exact Sciences (EXAS) over the last 7 years, with Sep 2019 value amounting to $188.4 million.

  • Exact Sciences' Non-cash Items rose 47.42% to $188.4 million in Q3 2019 from the same period last year, while for Sep 2019 it was $188.4 million, marking a year-over-year increase of 47.42%. This contributed to the annual value of $120.8 million for FY2018, which is 29.75% up from last year.
  • Per Exact Sciences' latest filing, its Non-cash Items stood at $188.4 million for Q3 2019, which was up 13,065.48% from $1.4 million recorded in Q2 2019.
  • Exact Sciences' Non-cash Items' 5-year high stood at $209.2 million during Q1 2019, with a 5-year trough of $1.4 million in Q2 2019.
  • Moreover, its 3-year median value for Non-cash Items was $120.8 million (2018), whereas its average is $110.1 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first skyrocketed by 156.94% in 2018, then crashed by 98.88% in 2019.
  • Over the past 5 years, Exact Sciences' Non-cash Items (Quarterly) stood at $41.1 million in 2015, then increased by 0.97% to $41.5 million in 2016, then skyrocketed by 124.34% to $93.1 million in 2017, then climbed by 29.75% to $120.8 million in 2018, then spiked by 47.42% to $188.4 million in 2019.
  • Its last three reported values are $188.4 million in Q3 2019, $1.4 million for Q2 2019, and $209.2 million during Q1 2019.